Volume 46, Issue 2, Supplement 2 , Pages S4-S8, February 2010
Adolescents at Risk: The Case for Meningococcal Vaccine
Abstract
The clinical course of meningococcal disease represents a diagnostic challenge because early symptoms are often nonspecific and overlap with those of other common infections before rapidly progressing to a life-threatening condition. Clinicians need to prioritize vaccination of preadolescent, adolescent, and other patients who are at risk of meningococcal disease, using a quadrivalent meningococcal conjugate vaccine at the soonest opportunity.
Keywords: Meningococcal infections/prevention and control, Meningitis vaccines/therapeutic use, Children, Adolescents, Case study
To access this article, please choose from the options below
PII: S1054-139X(09)00681-8
doi:10.1016/j.jadohealth.2009.12.013
© 2010 Society for Adolescent Medicine. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 2, Supplement 2 , Pages S4-S8, February 2010
